MRA/fMRI Study of Spontaneous Migraine
August 28, 2012 updated by: Faisal Mohammad Amin, Glostrup University Hospital, Copenhagen
Functional MRI and MR Angiography Used in Spontaneous Migraine
The purpose of this study is to examine migraineurs during spontaneous migraine attacks without aura, using high resolution magnetic resonance imaging (MRI), to study following:
- Changes in resting state blood-oxygenation-level-dependent-signal (BOLD-signal) using functional MRI (fMRI).
- Changes in circumferences of intra- and extracranial arteries using MR-angiography (MRA).
- Changes in regional and global cerebral blood flow (CBF) using the arterial spin labeling (ASL) method.
Moreover to perform diffusion tensor imaging (DTI) scans during spontaneous migraine attacks.
The migraine specific drug sumatriptan will be given to relieve pain and the effect will be registered using MRA and fMRI if possible.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Glostrup, Denmark, DK-2600
- Recruiting
- Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen
-
Contact:
- Faisal Amin, MD, PhD student
- Phone Number: +4538633066
- Email: famoam01@regionh.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Migraine without aura
Description
Inclusion Criteria:
- Migraine without aura according to IHS criteria.
Exclusion Criteria:
- Other primary headaches.
- Tension-type headache more than 5 days/month.
- Use of anti-pain medication before the scanning on the examination day.
- Pregnant or nursing women.
- Contraindication for MR scan.
- Anamnestic or clinical signs of cardiovascular or cerebrovascular disease, unregulated psychiatric disease or drug misuse.
- Other clinical conditions assessed by the examining doctor.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Spontaneous migraine
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
November 10, 2011
First Submitted That Met QC Criteria
November 14, 2011
First Posted (Estimate)
November 15, 2011
Study Record Updates
Last Update Posted (Estimate)
August 29, 2012
Last Update Submitted That Met QC Criteria
August 28, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-C-2008-089
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.